Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.

Skin has specialized touch receptors that can tell different sensations apart.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Targeting the skin's endocannabinoid system could help treat skin disorders.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Air pollution (PM10) increases skin inflammation and aging by reducing collagen and may trigger a repair response in skin cells.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Drug addicts often have scars, skin color changes, blocked veins, and bruising, with severe ulcers from barbiturate injections.

Stem cells help repair tissue mainly by releasing beneficial substances, not by replacing damaged cells.

Premature graying of hair may suggest health issues and currently lacks effective treatments.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Mutations in the spike protein affect drug binding and effectiveness.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Autophagy is important for human hair growth and health.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Organoids can help study COVID-19 and develop treatments, but face challenges like instability and limited renewal.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Type I interferons play a key role in the development of various skin diseases.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

Micro-segmental hair analysis helps detect drug use patterns and estimate drug consumption days.